Diprivan and Cognitive disorder - a phase IV clinical study of FDA data

Summary:

Cognitive disorder is reported as a side effect among people who take Diprivan (propofol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fentanyl, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Cognitive disorder when taking Diprivan. It is created by eHealthMe based on reports of 6,477 people who have side effects when taking Diprivan from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Cognitive disorder?

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 1,649 drugs and 1,728 conditions by eHealthMe. Check the latest studies of Cognitive disorder.

On Aug, 06, 2026

6,477 people reported to have side effects when taking Diprivan.
Among them, 12 people (0.19%) have Cognitive disorder.

Could Diprivan cause Cognitive disorder?

Among these 12 people:

How long have people been on Diprivan when they have Cognitive disorder? *

What is the gender of people who have Cognitive disorder when taking Diprivan? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Cognitive disorder when taking Diprivan? *

What are other drugs people take besides Diprivan? *

What are other side effects people have besides Cognitive disorder? *

Confusional State: 5 people, 41.67%
Confusion: 4 people, 33.33%
Memory Loss: 4 people, 33.33%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 25.00%
Balance Disorder: 3 people, 25.00%
Cardiac Arrest: 3 people, 25.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 25.00%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 3 people, 25.00%
Fever: 3 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%

What are the existing conditions these people have? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 16.67%
Sedation: 2 people, 16.67%
Pneumonia: 2 people, 16.67%
Bipolar Disorder (mood disorder): 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Pain: 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and have Cognitive disorder?

- Check whether Cognitive disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprivan:

Diprivan (6,496 reports)

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cognitive disorder:

Cognitive disorder (1,649 drugs)

Browse all the conditions that are associated with Cognitive disorder:

Cognitive disorder (1,728 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on propofol (the active ingredients of Diprivan) and Diprivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.